Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Interleukin-12 in Treating Patients With Cancer in the Abdomen
This study is ongoing, but not recruiting participants.
Study NCT00003046 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anal Cancer
Carcinoma of the Appendix
Colorectal Cancer
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Carcinoid Tumor
Malignant Mesothelioma
Pancreatic Cancer
Small Intestine Cancer
Additional conditions recognized in this trial
Anus Neoplasms
Bile Duct Neoplasms
Carcinoid Tumor
Carcinoma
Colonic Neoplasms
Colorectal Neoplasms
Duodenal Neoplasms
Gallbladder Neoplasms
Gastrointestinal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Malignant Carcinoid Syndrome
Mesothelioma
Pancreatic Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adenoma
Anus Diseases
Bile Duct Diseases
Biliary Tract Diseases
Biliary Tract Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gallbladder Diseases
Gastrointestinal Diseases
Ileal Diseases
Intestinal Diseases
Jejunal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Pancreatic Diseases
Rectal Diseases
Rectal Neoplasms
Stomach Diseases
Interventions listed in this trial
recombinant interleukin-12
Additional drug interventions recognized in this trial
Interleukin-12
More general drug interventions related to this trial
Adjuvants, Immunologic
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
